BHIC (BioScience Health Innovations) Accounts Payable: $0.01 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BHIC BioScience Health Innovations Inc BHIC
47 GF Score
Price $4.04
GF Value $164.84
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is BioScience Health Innovations Accounts Payable?

BioScience Health Innovations BHIC 47 Accounts Payable is $0.01 Mil as of Mar. 2026. GuruFocus rates BHIC with a GF Score™ of 47/100 and a GF Value™ of $164.84 (Possible Value Trap). The stock has 5 warning signs investors should review.

BioScience Health Innovations's Accounts Payable for the quarter that ended in Mar. 2026 was $0.01 Mil.

BioScience Health Innovations's quarterly Accounts Payable declined from Sep. 2025 ($0.01 Mil) to Dec. 2025 ($0.01 Mil) but then increased from Dec. 2025 ($0.01 Mil) to Mar. 2026 ($0.01 Mil).

BioScience Health Innovations's annual Accounts Payable stayed the same from Dec. 2023 ($0.01 Mil) to Dec. 2024 ($0.01 Mil) but then declined from Dec. 2024 ($0.01 Mil) to Dec. 2025 ($0.01 Mil).

BioScience Health Innovations Accounts Payable Related Terms

BioScience Health Innovations Accounts Payable Historical Data

* Premium members only.

The historical data trend for BioScience Health Innovations's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioScience Health Innovations Accounts Payable Chart

BioScience Health Innovations Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.00 0.00 0.01 0.01 0.01

BioScience Health Innovations Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.01 0.01 0.01
BHIC
47GF Score
BioScience Health Innovations Inc BHIC
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioScience Health Innovations Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.01 Mil mean?
BioScience Health Innovations (BHIC) has a Accounts Payable of $0.01 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on BioScience Health Innovations and its competitors.
Is BioScience Health Innovations' Accounts Payable too high?
BioScience Health Innovations' current Accounts Payable is $0.01 Mil. Overall, BioScience Health Innovations has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioScience Health Innovations' Accounts Payable compare to SHFH and PETS?
BioScience Health Innovations' Accounts Payable of $0.01 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Providers & Services company?
A good Accounts Payable depends on the Healthcare Providers & Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on BioScience Health Innovations and its competitors. BioScience Health Innovations's current Accounts Payable is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioScience Health Innovations stock overvalued right now?
Based on GuruFocus' analysis, BioScience Health Innovations (BHIC) is currently considered Possible Value Trap. The stock's GF Value™ is $164.84, compared to a current price of $4.04 — trading 97.5% below its estimated fair value. The current Accounts Payable is $0.01 Mil. BioScience Health Innovations' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For BioScience Health Innovations (BHIC), the current Accounts Payable is $0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioScience Health Innovations (BHIC) Overvalued in 2026?

Based on GuruFocus' analysis, BioScience Health Innovations stock appears to be undervalued. The current stock price of $4.04 is trading 97.5% below its estimated GF Value™ of $164.84. GuruFocus considers BioScience Health Innovations to be Possible Value Trap.

Key valuation signals for BHIC:

  • Accounts Payable: $0.01 Mil
  • GF Value™: $164.84 vs. price of $4.04 (97.5% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the BHIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioScience Health Innovations Business Description

Address 14857 South Concord Park Drive, Bluffdale, UT, USA, 84065
BioScience Health Innovations Inc is engaged in full-scale operations as a distributor and generates revenue. The company's main business is to sell clinically tested, affordably priced products to naturally battle the onslaught of bacteria and viruses through online sales and various other distribution channels. The company develops, manufactures, and distributes science-backed nutritional supplements and delivery systems targeting cellular health, mitochondrial optimization, hormonal balance, and longevity.
47GF Score

Get the complete analysis for BHIC

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.04
Price
$164.84
GF Value